Lenmid 5 mg (Lenmidomide)

Lenmid 5 mg

Lenmid 5Mg Capsule is used to treat anemia, which occurs in patients suffering from myelodysplastic syndrome (MDS). The medicine is used in combination with certain other medications to treat multiple myeloma(MM). Some patients suffering from mantle cell lymphoma (MCL) may also receive this treatment, as it is an immunomodulator.

This medication should not be taken if your body is hypersensitive to any substance present in it. Moreover, the medicine can harm a fetus, thus it should not be used by women who are expecting or those trying to conceive. Breastfeeding mothers should consult their medical providers before taking this medication.

The drug is meant to be taken orally, with or without food. Swallow the tablet as a whole do not chew, cut or break it.

Information given here is based on the salt content of the medicine. Uses and effects of the medicine may vary from person to person. It is advisable to consult a Oncologist before using this medicine.

Use

The medication can treat the below provided problems:

Haemolytic Anemia

Multiple Myeloma

Mantle Cell Lymphoma

Dosage

Lenmid 5 mg
Lenmid 10 mg
Lenmid 25 mg

Side Effects

A patient can suffer from the following side effects:

Headache

Nausea

Rash

Dizziness

Edema (Swelling)

Loss Of Appetite

Decreased White Blood Cell Count

Decreased Calcium Level

Muscle Weakness

Fatigue

Fever

Dry Skin

Weight Loss

Neuropathy

Constipation

Tremor

Dosage

Are there any overdose instructions?

Seek emergency medical treatment or contact the doctor in case of an overdose.
Are there any missed dose instructions?

If you miss a dose of this medicine, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.

Work

This medicine is derived from thalidomide and is used for treating multiple myeloma and other cancers. It works in double mechanism mainly-in vitro and in vivo. In in vitro, tumour cells are disrupted from growing, angiogenesis is prevented and stimulates immunomodulation. In vivo, tumour cells are killed where bone marrow stromal cell support is inhibited and maintaining osteoclastogenic effects. Lenalidomide belongs to a class of immunomodulatory drugs.